N I Stocks
About
In The Last Decade
N I Stocks
13 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Immunology 768
- Virology 675
- Epidemiology 314
- Infectious Diseases 294
- Molecular Biology 91
Countries citing papers authored by N I Stocks
This map shows the geographic impact of N I Stocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N I Stocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N I Stocks more than expected).
Fields of papers citing papers by N I Stocks
This network shows the impact of papers produced by N I Stocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N I Stocks. The network helps show where N I Stocks may publish in the future.
Co-authorship network of co-authors of N I Stocks
This figure shows the co-authorship network connecting the top 25 collaborators of N I Stocks. A scholar is included among the top collaborators of N I Stocks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N I Stocks. N I Stocks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 69 | |
| 2 | 16 | |
| 3 | 21 | |
| 4 | 62 | |
| 5 | 19 | |
| 6 | Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. breakdown → | 540 |
| 7 | 187 | |
| 8 | Limiting-dilution analysis of human CTL differentiation. Requirement for a lymphokine-mediated differentiation signal. | 7 |
| 9 | 38 | |
| 10 | Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine. | 7 |
| 11 | 157 | |
| 12 | 18 | |
| 13 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.